Successfully represented Anthem and helped drive a favorable resolution of the HHS OCR regulatory investigation and related litigation related to high-profile data breach.
Created and implemented HIPAA and privacy compliance programs for numerous health care and life sciences companies.
Working with numerous pharmaceutical and life science companies in connection with their review and development of privacy compliance programs.
Advising a leading biotech company on data privacy matters with regard to clinical trials in the EU involving both Pan-European strategic advice and detailed country-specific guidance.
Advising a large medical device manufacturer on numerous and wide-ranging issues, including connected health initiatives, HIPAA compliance and incident response, investigations, and reporting.
Hogan Lovells Publications
17 December 2018
Investing in the life sciences industry without an understanding of the key regulatory factors that could determine a product’s success or failure could cost you millions of dollars.
Hogan Lovells Publications
13 December 2018
Hogan Lovells Publications
06 November 2018
Hogan Lovells Publications
19 October 2018
October is National Cybersecurity Awareness Month and the Food and Drug Administration (FDA or the agency) has been busy.
Hogan Lovells Publications
17 January 2018
From insulin pumps and pacemakers to defibrillators, medical devices increasingly rely on wireless and internet connectivity for efficient operations. Unfortunately, these interconnections...
Publications
07 August 2017
“The number one issue on the minds of many CEOs and boards is cyberattacks and data breaches,” said Hogan Lovells partner Marcy Wilder. In this hoganlovells.com interview,...
Recognized as top firm for Privacy and Data Security: Healthcare
Chambers USA
Tier 1 for UK Data Protection
The Legal 500 UK
Tier 1 for Data Protection & Privacy
The Legal 500 US
